The global hernia repair devices market size was valued at USD 4.63 billion in 2025 and is projected to grow from USD 4.9 billion in 2026 to USD 7.7 billion by 2034 at a CAGR of 5.8% during the forecast period 2026-2034.
One of the most frequently performed surgical procedures worldwide is hernia repair. Growing hernia rates, attractive reimbursement practices, and technological developments in repair devices are essential to market growth drivers. The high frequency of hernias is fueling an increase in demand for practical repair tools, which is anticipated to support market expansion.
Download Free Sample Report To learn more about this report,
One of the most frequently performed surgical procedures worldwide is hernia repair. Men are more prone to hernia than women t. Inguinal hernia affects 2% of women and 25% of men. Risk factors for this illness include age, smoking, obesity, and bad lifestyle choices. Adults experience approximately 75% of all hernias in the groin, which has led to an increase in the use of hernia repair devices among the group. According to HealthGrove, the annual mortality rate of hernia per 100,000 population is 0.5. According to the FDA, more than one million hernia repairs are performed annually across the U.S., of which around 800,000 are inguinal repairs. The high incidence of hernia generates demand for efficient hernia repair, contributing to market growth.
High incidence of hernia globally and improved patient outcomes by using meshes that reduce operative & recovery time are some key factors augmenting the market growth. The advantages of using meshes in hernia repair include alleviated pain and reduced chances of recurrence, which is expected to accelerate the market. In addition, mesh repair devices are available with elasticity and adaptable shapes that can match the changing dynamics of abdominal walls. The large pores in the mesh allow lower foreign body reaction and better soft tissue ingrowth, resulting in a flexible scar formation. Thus, the benefits associated with using meshes in hernia surgeries are anticipated to foster market growth.
Several manufacturers are developing efficient mesh repair devices. Many meshes are available for incisional repair, which is expected to fuel the overall market. Proceed Surgical Mesh by Ethicon, Sepramesh IP Composite by Bard Davol, and Parietex Composite (PCO) Mesh by Medtronic are some of the critical mesh products used in incisional hernia repairs.
Innovation and R&D can increase the cost of hernia repair devices. Several developing and underdeveloped economies face challenges in adopting hernia repair devices, owing to low disposable income, the high price of products, and the presence of limited facilities & resources. The high cost of hernia repair devices can prevent more patients from gaining access to treatments, as it increases the overall out-of-pocket expenditure. Thus, despite the availability of these devices, high costs may prevent their adoption and hence, may limit the sale of products. However, if funds are provided by governments or generated through various CSR initiatives while creating awareness, the impact of this restraint may be minimized.
In recent years, it has risen. Innovations like articulating fixation devices and self-fixating (gripping) meshes are created to solve the issues that arise during laparoscopic procedures. Additionally, these tools give surgeons better access to the abdominal wall's weak points and let them safely implant the mesh at the ideal body site, both of which are expected to drive up demand.
Several market players are developing and manufacturing highly flexible self-fixation hernia meshes, where the mesh can be fixed at the hernia site without glue or staples, owing to the emergence of micro-grip adherence technology. For instance, Medtronic developed the Parietex Progrip self-fixating mesh. This mesh is lightweight, comprises Polylactic Acid (PLA) & monofilament polyester, and is associated with a smaller operative period than sutured mesh. In addition, biologic allograft meshes, which offer a fast recovery rate and minimize postsurgical pain better than other options, are another factor predicted to enhance the hernia repair devices market during the forecast period. Thus, technological advancements in hernia repair devices are projected to propel the market.
Request Customizationto receive a tailored report.
The market is segmented into hernia mesh devices and hernia fixation devices. The hernia mesh devices segment dominated the market owing to the rapid adoption of these devices. It is anticipated to register a CAGR of 7.5% during the forecast period. The U.S. FDA stated that using hernia meshes may improve patient outcomes, as it can help decrease the overall recovery time. The FDA further stated that hernia meshes could be used in 90% of surgical procedures. The capacity to give long-term tensile strength to prevent a recurrence and infection resistance are the main factors contributing to this segment's supremacy.
The market is segmented into open procedure and laparoscopic procedure. The open procedure segment accounted for the largest market share and is estimated to grow at a CAGR of 7.6% during the forecast period. To do open hernia surgery, the abdomen must be extensively incised. To strengthen the tissues around the healed hernia, the surgical mesh is placed over it. The prevention of hernia recurrence, affordable operation, and reduced risk of postoperative complications are all advantages of open surgery.
The laparoscopic segment is expected to register the fastest growth rate over the forecast period, as they are widely accepted as a hernia treatment option. Due to benefits including shorter hospital stays, quicker healing, fewer cuts, and a lower infection rate, these minimally invasive procedures are advised. According to the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), roughly 175,000 laparoscopic ventral hernia procedures are performed annually in the U.S. Moreover, the introduction of Single Incision Laparoscopic Surgery (SILS) has offered a new surgical approach, driving the segment growth.
The market is segmented into the inguinal hernia, incisional hernia, umbilical hernia, femoral hernia, and others. The inguinal hernia segment accounted for the largest market share and is estimated to grow at a CAGR of 7.6% during the forecast period. Inguinal hernia, also known as herniorrhaphy, accounts for 75% of all hernias. According to Cleveland Clinic findings, males over 40 years are more likely to have inguinal hernias than females. The study further states that 25% of males and 2% of females are likely to develop an inguinal hernia in their lifetime. According to the Hernia Surge Group, in 2018, inguinal hernia repair was one of the most performed surgical procedures globally, performed on nearly 20 million patients annually. Inguinal hernia repair involves suture techniques, mesh repair, or laparoscopy. According to a meta-analysis by the EU Hernia Trialists Collaboration, recurrence post a mesh repair was a quarter of that after a sutured repair. Moreover, these devices facilitate tension-free procedures, unlike sutured techniques, which makes mesh repair a preferred option for most surgeons in treating inguinal hernias.
The incisional hernia segment is the second largest. An abdominal wall incision that has already been created or a surgical wound that has not fully healed are the two leading causes of incisional hernia. Incisional hernia is the second most common type after inguinal hernia. As per an article by Medscape in March 2021, incisional hernias accounted for 2% to 30% of the 4 million laparotomies performed in the U.S. Furthermore, 50% of incisional hernias occur within two years after surgery, while 74% of incisional hernias occur within three years. Incisional hernia accounts for 10% of all abdominal wall incisions. Incisional hernias are more common in women, as most women undergo midline abdominal surgery during childbirth. Risk factors for an incisional hernia include obesity, smoking, surgical site infections, impaired wound healing, malnutrition, and connective tissue disorders. The recurrence rate after the first surgical procedure for incisional hernia ranges from 25% to 52%. According to the American College of Surgeons, the rate of open surgeries involving mesh is lower than that in surgeries with sutures. Laparoscopy performed using a mesh can have a recurrence rate as low as 3.4%. Thus, mesh procedures are preferred for the treatment of incisional hernias.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest market share and is estimated to grow at a CAGR of 5.1% during the forecast period. The North American region includes the U.S. and Canada. A well-developed reimbursement network, favorable government funding, and increasing awareness are boosting hospital adoption of hernia repair devices. Furthermore, technological advancements in hernia repair devices are supporting market growth. In 2020, the market was dominated by North America. North America holds the highest percentage due to sedentary lifestyles, expensive treatment costs, an aging population, and a high hernia recurrence rate.
Europe is the second largest region. It is estimated to reach an expected value of USD 1340 million by 2030, exhibiting a CAGR of 5.8%. Hernia repair is among the standard surgical procedures performed in Europe. The manufacturers are focused on developing novel biodegradable mesh to minimize patient complications. In February 2016, an EU-funded Green Nano Mesh was launched for the bio-based, eco-friendly treatment of hernia, likely to cause lesser harm to patients. Green Nano Mesh is nano-scaled, fibrous, and biodegradable. It was developed with the help of green nanotechnology and sustainable resources sponsored by the pan-European organization. Multiple scientific techniques were used to develop these hernia meshes, such as freeze drying, green cross-linking, electro-spinning, dip coating, and supercritical CO2 technology. Furthermore, Technological advancements and the launch of efficient medical devices & therapies by industry players are among the major factors responsible for the market growth. The NHS recommends meshing implants for the treatment of hernia. An increasing number of surgeries is anticipated to augment the market growth. According to the Royal College of Surgeons of England, in 2018, around 78,733 inguinal hernia procedures were performed in England in 2017, of which 3,700 patients had severe symptoms. Growing product approvals by market players in the country are expected to be a significant growth contributor.
Asia Pacific hernia repair devices are expected to grow the fastest over the forecast period. Some factors driving the market expansion in this area are expanding medical tourism, declining treatment costs, technological advancements, and rising healthcare reimbursements. For instance, in October 2016, a comparative study was conducted to analyze the expenses patients incur from hernia mesh repair in developed and developing countries. It was observed that the expense of laparoscopic inguinal hernia mesh repair for a patient in Germany was approximately USD 3,500, whereas it was USD 23,294 in the U.S. However, the expense of similar treatments in Asia Pacific countries such as Japan was estimated to be JPY 120,000 (approximately USD 1,200), which is considerably cheaper than treatment in the U.S. Additionally, Asian nations, particularly Japan and China, are seeing an increase in the need for hernia repair tools. In addition, the prevalence of hernia is higher in developing countries than in developed countries owing to a large number of undiagnosed and untreated hernia cases, which is expected to boost further the growth and development of the hernia repair devices market in this region.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com